Bay Area cancer-fighting startup acquired for up to $9.8B in blockbuster deal

Pharmaceutical giant AbbVie on Thursday said it will acquire South San Francisco cancer drug startup Stemcentrx in a deal that could be worth up to $9...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.